Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

10.1200/JCO.2017.77.0388

Saved in:
Bibliographic Details
Main Authors: Ma, Brigette BY, Lim, Wan-Teck, Goh, Boon-Cher, Hui, Edwin P, Lo, Kwok-Wai, Pettinger, Adam, Foster, Nathan R, Riess, Jonathan W, Agulnik, Mark, Chang, Alex YC, Chopra, Akhil, Kish, Julie A, Chung, Christine H, Adkins, Douglas R, Cullen, Kevin J, Gitlitz, Barbara J, Lim, Dean W, To, Ka-Fai, Chan, KC Allen, Lo, YM Dennis, King, Ann D, Erlichman, Charles, Yin, Jun, Costello, Brian A, Chan, Anthony TC
Other Authors: MEDICINE
Format: Article
Language:English
Published: AMER SOC CLINICAL ONCOLOGY 2024
Subjects:
Science & Technology
Life Sciences & Biomedicine
Oncology
BARR-VIRUS DNA
PD-L1 EXPRESSION
CELL CARCINOMA
THERAPY
CANCER
MELANOMA
MUTATIONS
BLOCKADE
ESCAPE
SUBSET
Online Access:https://scholarbank.nus.edu.sg/handle/10635/248960
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English

Internet

https://scholarbank.nus.edu.sg/handle/10635/248960

Similar Items